论文部分内容阅读
目的 对 12 0例经病理证实为食管癌 (自 1985年 3月～ 1995年 3月 )病人所采用的不同治疗方法和效果进行了回顾性分析。方法 单纯放疗组 35例 ( 组 ) ,先放疗后化疗组 34例 ( 组 ) ,先化疗后放疗组 31例 ( 组 ) ,放疗 +化疗同时治疗组 2 0例 ( 组 )。放疗剂量 5 0～ 70 Gy,2 Gy/日。化疗药物以 PDD、PYM、5 - Fu、VCR为主的联合方案。结果 总的 1,3,5年生存率为 88% ,2 7.5 % ,13.3%。 、 、 和 组 1,3,5年生存率分别为 80 %、17.1%、11.4% ;91.2 %、47.1%、17.6 % ;87.1%、16 .1%、16 .1% ;10 0 %、30 %、5 %。结论 组 3年生存率优于其他 3个治疗组 (P<0 .0 5 )
Objective To retrospectively analyze the different treatment methods and effects of 120 patients with pathologically confirmed esophageal cancer (from March 1985 to March 1995). Methods 35 cases of radiotherapy alone group, 34 cases of chemotherapy group after radiotherapy, 31 cases of radiotherapy group before radiotherapy and 20 cases of radiotherapy plus chemotherapy group. Radiation dose 50 ~ 70 Gy, 2 Gy / day. Chemotherapy drugs with PDD, PYM, 5 - Fu, VCR - based joint program. Results The overall 1, 3, 5-year survival rates were 88%, 2 7.5%, 13.3%. , And 1, 3, 5-year survival rates were 80%, 17.1%, 11.4%, 91.2%, 47.1%, 17.6%, 87.1%, 16.1%, 16.1%, 10%, 30% %, 5%. Conclusions The 3-year survival rate of the group is better than the other 3 treatment groups (P0.05)